Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Plasminogen Activator Inhibitor 2"" wg kryterium: Temat


Tytuł:
circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinoma.
Autorzy:
Xu L; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province, 610041, China.
Wang P; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province, 610041, China.
Li L; Institute of Clinical Pathology, West China Hospital of Sichuan University, Chengdu, 610041, China.
Li L; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province, 610041, China.
Huang Y; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province, 610041, China.
Zhang Y; Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China.
Zheng X; Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, 610041, China.
Yi P; Department of Hepato-biliary-pancrease, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, 637000, China.
Zhang M; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province, 610041, China. .
Xu M; Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Lane, Wuhou District, Chengdu, Sichuan Province, 610041, China. .; Department of Hepatopancreatobiliary Surgery, Meishan City People's Hospital, Meishan Hospital of West China Hospital, Sichuan University, Meishan, 620000, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2023 Oct 26; Vol. 22 (1), pp. 174. Date of Electronic Publication: 2023 Oct 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Humans ; RNA, Circular/genetics ; Urokinase-Type Plasminogen Activator/genetics ; Urokinase-Type Plasminogen Activator/metabolism ; RNA/genetics ; Plasminogen Activator Inhibitor 2/genetics ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
The role of plasminogen activator inhibitor-2 in pneumococcal meningitis.
Autorzy:
Teske NC; Laboratory of Neuroinfectious Diseases, Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians University, Munich, Germany.; Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, PO Box 22660, 1100 DD, Amsterdam, The Netherlands.; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Infections of the Brain (ESGIB), Basel, Switzerland.
Engelen-Lee JY; Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, PO Box 22660, 1100 DD, Amsterdam, The Netherlands.; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Infections of the Brain (ESGIB), Basel, Switzerland.
Dyckhoff-Shen S; Laboratory of Neuroinfectious Diseases, Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians University, Munich, Germany.
Pfister HW; Laboratory of Neuroinfectious Diseases, Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians University, Munich, Germany.
Klein M; Laboratory of Neuroinfectious Diseases, Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians University, Munich, Germany.; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Infections of the Brain (ESGIB), Basel, Switzerland.
van de Beek D; Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, PO Box 22660, 1100 DD, Amsterdam, The Netherlands.; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Infections of the Brain (ESGIB), Basel, Switzerland.
Kirschning CK; Institute of Medical Microbiology, University of Duisburg-Essen, Essen, Germany.
Koedel U; Laboratory of Neuroinfectious Diseases, Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians University, Munich, Germany.; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Infections of the Brain (ESGIB), Basel, Switzerland.
Brouwer MC; Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, PO Box 22660, 1100 DD, Amsterdam, The Netherlands. .; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Infections of the Brain (ESGIB), Basel, Switzerland. .
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2022 Oct 29; Vol. 10 (1), pp. 155. Date of Electronic Publication: 2022 Oct 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Meningitis, Pneumococcal*/genetics
Humans ; Mice ; Animals ; Plasminogen Activator Inhibitor 2/genetics ; Interleukin-10 ; Mice, Knockout ; RNA, Messenger ; Mice, Inbred C57BL
Czasopismo naukowe
Tytuł:
Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model.
Autorzy:
Furuya H; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA. .; Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI, 96822, USA. .; Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Davis Research Building, 110 N. George Burns Road, Los Angeles, CA, 90048, USA. .
Hayashi K; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.; Department of Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Shimizu Y; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.; Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI, 96822, USA.
Kim N; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.
Tsukikawa Y; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.
Chen R; Department of Computer Science and Engineering, State University of New York at Buffalo, Buffalo, NY, 14203, USA.
Sun Y; Department of Computer Science and Engineering, State University of New York at Buffalo, Buffalo, NY, 14203, USA.; Department of Microbiology and Immunology, State University of New York at Buffalo, Buffalo, NY, 14203, USA.
Chan OTM; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.
Pagano I; Cancer Prevention in Pacific Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.
Peres R; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.
Hokutan K; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.; Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI, 96822, USA.
Igari F; Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Davis Research Building, 110 N. George Burns Road, Los Angeles, CA, 90048, USA.
Chan KS; Department of Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Rosser CJ; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.; Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI, 96822, USA.; Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Davis Research Building, 110 N. George Burns Road, Los Angeles, CA, 90048, USA.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2020 Feb 05; Vol. 18 (1), pp. 57. Date of Electronic Publication: 2020 Feb 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Plasminogen Activator Inhibitor 1*/genetics
Plasminogen Activator Inhibitor 2*/genetics
Urinary Bladder Neoplasms*/chemically induced
Urinary Bladder Neoplasms*/genetics
Animals ; Mice ; Mice, Knockout ; Nitrosamines ; Serpin E2
Czasopismo naukowe
Tytuł:
SerpinB2 inhibits migration and promotes a resolution phase signature in large peritoneal macrophages.
Autorzy:
Schroder WA; QIMR Berghofer Medical Research Institute, Brisbane, Qld, 4029, Australia.
Hirata TD; School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Le TT; QIMR Berghofer Medical Research Institute, Brisbane, Qld, 4029, Australia.
Gardner J; QIMR Berghofer Medical Research Institute, Brisbane, Qld, 4029, Australia.
Boyle GM; QIMR Berghofer Medical Research Institute, Brisbane, Qld, 4029, Australia.
Ellis J; QIMR Berghofer Medical Research Institute, Brisbane, Qld, 4029, Australia.
Nakayama E; Department of Virology I, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
Pathirana D; QIMR Berghofer Medical Research Institute, Brisbane, Qld, 4029, Australia.
Nakaya HI; School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Suhrbier A; QIMR Berghofer Medical Research Institute, Brisbane, Qld, 4029, Australia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Aug 27; Vol. 9 (1), pp. 12421. Date of Electronic Publication: 2019 Aug 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell Movement*
Macrophages, Peritoneal/*metabolism
Plasminogen Activator Inhibitor 2/*metabolism
Animals ; Extracellular Matrix/genetics ; Extracellular Matrix/metabolism ; Macrophages, Peritoneal/cytology ; Mice ; Mice, Knockout ; Plasminogen Activator Inhibitor 2/genetics ; Urokinase-Type Plasminogen Activator/genetics ; Urokinase-Type Plasminogen Activator/metabolism
Czasopismo naukowe
Tytuł:
The role of the platelet pool of Plasminogen Activator Inhibitor-1 in well-controlled type 2 diabetes patients.
Autorzy:
Mossberg K; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Göteborg, Sweden.; Department of Public Health and Community Medicine, Sahlgrenska University Hospital, Göteborg, Sweden.
Olausson J; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Göteborg, Sweden.; The Wallenberg Laboratory for Cardiovascular Research, Göteborg, Sweden.
Fryk E; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Göteborg, Sweden.; The Wallenberg Laboratory for Cardiovascular Research, Göteborg, Sweden.
Jern S; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Göteborg, Sweden.; The Wallenberg Laboratory for Cardiovascular Research, Göteborg, Sweden.
Jansson PA; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Göteborg, Sweden.; The Wallenberg Laboratory for Cardiovascular Research, Göteborg, Sweden.
Brogren H; Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Aug 31; Vol. 17 (8), pp. e0267833. Date of Electronic Publication: 2022 Aug 31 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/metabolism
Plasminogen Activator Inhibitor 1*/metabolism
Blood Platelets/metabolism ; Humans ; Obesity ; Plasminogen Activator Inhibitor 2/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Tissue Plasminogen Activator/metabolism
Czasopismo naukowe
Tytuł:
PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity.
Autorzy:
Furuya H; Department of Biomedical Science, Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA. .
Sasaki Y; Department of Biomedical Science, Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.
Chen R; Department of Microbiology and Immunology, State University of New York at Buffalo, Buffalo, NY, 14260, USA.
Peres R; Clinical and Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.
Hokutan K; Clinical and Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.; Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI, 96813, USA.
Murakami K; Department of Biomedical Science, Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.
Kim N; Department of Biomedical Science, Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.
Chan OTM; Clinical and Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.
Pagano I; Cancer Prevention in Pacific Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.
Dyrskjøt L; Department of Molecular Medicine, Aarhus University Hospital, 8200, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, 8200, Århus, Denmark.
Jensen JB; Department of Clinical Medicine, Aarhus University, 8200, Århus, Denmark.; Department of Urology, Aarhus University Hospital, 8200, Århus, Denmark.
Malmstrom PU; Department of Surgical Sciences, Uppsala University, 751 05, Uppsala, Sweden.
Segersten U; Department of Surgical Sciences, Uppsala University, 751 05, Uppsala, Sweden.
Sun Y; Department of Microbiology and Immunology, State University of New York at Buffalo, Buffalo, NY, 14260, USA.
Arab A; Department of Biochemistry and Biophysics, Department of Urology, University of California San Francisco, San Francisco, CA, 94143, USA.
Goodarzi H; Department of Biochemistry and Biophysics, Department of Urology, University of California San Francisco, San Francisco, CA, 94143, USA.
Goodison S; Quantitative Health Sciences, Mayo Clinic Florida, Jacksonville, FL, 32224, USA.
Rosser CJ; Department of Biomedical Science, Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jul 16; Vol. 12 (1), pp. 12186. Date of Electronic Publication: 2022 Jul 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Urinary Bladder Neoplasms*/genetics
Plasminogen Activator Inhibitor 1/*metabolism
Humans ; Neovascularization, Pathologic ; Plasminogen Activator Inhibitor 1/genetics ; Plasminogen Activator Inhibitor 2 ; Tissue Plasminogen Activator ; Urokinase-Type Plasminogen Activator/metabolism
Czasopismo naukowe
Tytuł:
SerpinB2 is involved in cellular response upon UV irradiation.
Autorzy:
Majoros H; Department of Biochemistry and Molecular Biology, University of Szeged, Faculty of Science and Informatics, Szeged, Hungary.
Ujfaludi Z; Department of Biochemistry and Molecular Biology, University of Szeged, Faculty of Science and Informatics, Szeged, Hungary.
Borsos BN; Department of Biochemistry and Molecular Biology, University of Szeged, Faculty of Science and Informatics, Szeged, Hungary.
Hudacsek VV; Department of Biochemistry and Molecular Biology, University of Szeged, Faculty of Science and Informatics, Szeged, Hungary.
Nagy Z; Department of Functional Genomics and Cancer, Institute of Genetics and Molecular and Cellular Biology (IGBMC), Illkirch, France.
Coin F; Department of Functional Genomics and Cancer, Institute of Genetics and Molecular and Cellular Biology (IGBMC), Illkirch, France.
Buzas K; Institute of Biochemistry, Biological Research Centre, Szeged, Hungary.
Kovács I; Department of Pathology of the Gyula Kenézy University Hospital, University of Debrecen, Debrecen, Hungary.
Bíró T; Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.; Hungarian Center of Excellence for Molecular Medicine, Szeged, Hungary.
Boros IM; Department of Biochemistry and Molecular Biology, University of Szeged, Faculty of Science and Informatics, Szeged, Hungary.; Institute of Biochemistry, Biological Research Centre, Szeged, Hungary.
Pankotai T; Department of Biochemistry and Molecular Biology, University of Szeged, Faculty of Science and Informatics, Szeged, Hungary. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Feb 26; Vol. 9 (1), pp. 2753. Date of Electronic Publication: 2019 Feb 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA Damage*
DNA Repair*
Melanoma/*pathology
Osteosarcoma/*pathology
Plasminogen Activator Inhibitor 2/*metabolism
Ultraviolet Rays/*adverse effects
Bone Neoplasms/etiology ; Bone Neoplasms/pathology ; Carcinoma, Basal Cell/etiology ; Carcinoma, Basal Cell/pathology ; DNA Helicases/genetics ; DNA Helicases/metabolism ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Humans ; Melanoma/etiology ; Osteosarcoma/etiology ; Plasminogen Activator Inhibitor 2/genetics ; Pyrimidine Dimers ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł:
In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines.
Autorzy:
Baldini E; Department of Surgical Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
Presutti D; Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Monterotondo, 00015 Rome, Italy.
Favoriti P; Department of Surgical Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
Santini S; Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Monterotondo, 00015 Rome, Italy.
Papoff G; Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Monterotondo, 00015 Rome, Italy.
Tuccilli C; Department of Surgical Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
Carletti R; Department of Radiological, Oncological and Pathological Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
Di Gioia C; Department of Radiological, Oncological and Pathological Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
Lori E; Department of Surgical Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
Ferent IC; Department of Surgical Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
Gagliardi F; Department of Surgical Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
Catania A; Department of Surgical Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
Pironi D; Department of Surgical Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
Tripodi D; Department of Surgical Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
D'Andrea V; Department of Surgical Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
Sorrenti S; Department of Surgical Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
Ruberti G; Institute of Biochemistry and Cell Biology (IBBC), National Research Council (CNR), Monterotondo, 00015 Rome, Italy.
Ulisse S; Department of Surgical Sciences, 'Sapienza' University of Rome, 00161 Rome, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Mar 28; Vol. 23 (7). Date of Electronic Publication: 2022 Mar 28.
Typ publikacji:
Journal Article
MeSH Terms:
Thyroid Carcinoma, Anaplastic*/drug therapy
Thyroid Neoplasms*/pathology
Cell Line ; Humans ; Neoplasm Invasiveness ; Peptides, Cyclic ; Plasminogen Activator Inhibitor 1/metabolism ; Plasminogen Activator Inhibitor 2 ; Urokinase-Type Plasminogen Activator/metabolism
Czasopismo naukowe
Tytuł:
Zinc Favors Triple-Negative Breast Cancer's Microenvironment Modulation and Cell Plasticity.
Autorzy:
Vogel-González M; Laboratory of Molecular Physiology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
Musa-Afaneh D; Laboratory of Molecular Physiology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
Rivera Gil P; Integrative Biomedical Materials and Nanomedicine Lab, Department of Experimental and Health Sciences, Pompeu Fabra University, 08003 Barcelona, Spain.
Vicente R; Laboratory of Molecular Physiology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Aug 25; Vol. 22 (17). Date of Electronic Publication: 2021 Aug 25.
Typ publikacji:
Journal Article
MeSH Terms:
Tumor Microenvironment*
Triple Negative Breast Neoplasms/*metabolism
Zinc/*metabolism
Cation Transport Proteins/genetics ; Cation Transport Proteins/metabolism ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Humans ; Plasminogen Activator Inhibitor 2/genetics ; Plasminogen Activator Inhibitor 2/metabolism
Czasopismo naukowe
Tytuł:
Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.
Autorzy:
Pechlivani N; Division of Cardiovascular & Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds LS2 9JT, UK.
Kearney KJ; Division of Cardiovascular & Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds LS2 9JT, UK.
Ajjan RA; Division of Cardiovascular & Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds LS2 9JT, UK.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Nov 21; Vol. 22 (22). Date of Electronic Publication: 2021 Nov 21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carboxypeptidase B2/*genetics
Fibrinogen/*genetics
Hemorrhage/*therapy
alpha-2-Antiplasmin/*genetics
Anticoagulants ; Complement C3/genetics ; Fibrinolysis/genetics ; Hemorrhage/genetics ; Humans ; Plasminogen Activator Inhibitor 2/genetics ; Thrombosis/genetics
Czasopismo naukowe
Tytuł:
Down-regulation of SerpinB2 is associated with gefitinib resistance in non-small cell lung cancer and enhances invadopodia-like structure protrusions.
Autorzy:
Bae SY; College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 151-742, Korea.
Park HJ; College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 151-742, Korea.
Hong JY; College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 151-742, Korea.
Lee HJ; College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 151-742, Korea.
Lee SK; College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 151-742, Korea.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 Aug 25; Vol. 6, pp. 32258. Date of Electronic Publication: 2016 Aug 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Down-Regulation*
Drug Resistance, Neoplasm*
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*biosynthesis
Carcinoma, Non-Small-Cell Lung/*metabolism
Lung Neoplasms/*metabolism
Neoplasm Proteins/*biosynthesis
Plasminogen Activator Inhibitor 2/*biosynthesis
Pseudopodia/*metabolism
Quinazolines/*pharmacology
Biomarkers, Tumor/genetics ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Line, Tumor ; Gefitinib ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Neoplasm Proteins/genetics ; Plasminogen Activator Inhibitor 2/genetics ; Pseudopodia/genetics ; Pseudopodia/pathology
Czasopismo naukowe
Tytuł:
Skin equivalent tensional force alters keloid fibroblast behavior and phenotype.
Autorzy:
Suarez E; Plastic & Reconstructive Surgery Research, Manchester Institute of Biotechnology, University of Manchester, Manchester, United Kingdom; Bioengineering Group, School of Materials, University of Manchester, Manchester, United Kingdom.
Syed F
Rasgado TA
Walmsley A
Mandal P
Bayat A
Pokaż więcej
Źródło:
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society [Wound Repair Regen] 2014 Sep-Oct; Vol. 22 (5), pp. 557-68.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Stress, Mechanical*
Fibroblasts/*metabolism
HSP27 Heat-Shock Proteins/*genetics
Integrin alpha2beta1/*genetics
Keloid/*genetics
Plasminogen Activator Inhibitor 2/*genetics
RNA, Messenger/*metabolism
Wound Healing/*genetics
Adolescent ; Adult ; Aged ; Case-Control Studies ; Extracellular Matrix/metabolism ; Female ; Fibroblasts/pathology ; Gene Expression Regulation ; HSP27 Heat-Shock Proteins/metabolism ; Heat-Shock Proteins ; Humans ; Integrin alpha2beta1/metabolism ; Keloid/metabolism ; Keloid/pathology ; Male ; Middle Aged ; Molecular Chaperones ; Plasminogen Activator Inhibitor 2/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Wound Healing/physiology ; Young Adult
Czasopismo naukowe
Tytuł:
Tumor cell-expressed SerpinB2 is present on microparticles and inhibits metastasis.
Autorzy:
Schroder WA; Inflammation Biology Group, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, 4029, Australia.
Major LD
Le TT
Gardner J
Sweet MJ
Janciauskiene S
Suhrbier A
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2014 Jun; Vol. 3 (3), pp. 500-13. Date of Electronic Publication: 2014 Mar 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Melanoma, Experimental/*genetics
Neoplasm Metastasis/*genetics
Plasminogen Activator Inhibitor 2/*biosynthesis
Animals ; Cell-Derived Microparticles ; Gene Expression Regulation, Neoplastic ; Humans ; Melanoma, Experimental/pathology ; Mice ; Neoplasm Metastasis/pathology ; Phosphatidylserines/metabolism ; Plasminogen Activator Inhibitor 2/genetics ; Prognosis ; Protein Binding ; Urokinase-Type Plasminogen Activator/genetics ; Urokinase-Type Plasminogen Activator/metabolism
Czasopismo naukowe
Tytuł:
SASP-Dependent Interactions between Senescent Cells and Platelets Modulate Migration and Invasion of Cancer Cells.
Autorzy:
Valenzuela CA; Center for Medical Research, Medical School, University of Talca, Talca 3460000, Chile. .; Núcleo Científico Multidisciplinario, Universidad de Talca, Talca 3460000, Chile. .
Quintanilla R; Center for Medical Research, Medical School, University of Talca, Talca 3460000, Chile. r_.; Faculty of Health Sciences, University of Talca, Talca 3460000, Chile. r_.
Olate-Briones A; Center for Medical Research, Medical School, University of Talca, Talca 3460000, Chile. .
Venturini W; Center for Medical Research, Medical School, University of Talca, Talca 3460000, Chile. .; Faculty of Health Sciences, University of Talca, Talca 3460000, Chile. .
Mancilla D; Center for Medical Research, Medical School, University of Talca, Talca 3460000, Chile. .
Cayo A; Center for Medical Research, Medical School, University of Talca, Talca 3460000, Chile. .; Faculty of Health Sciences, University of Talca, Talca 3460000, Chile. .
Moore-Carrasco R; Faculty of Health Sciences, University of Talca, Talca 3460000, Chile. .; Programa de Investigación Asociativa en Cáncer Gástrico (PIA-CG), Talca 3460000, Chile. .
Brown NE; Center for Medical Research, Medical School, University of Talca, Talca 3460000, Chile. .; Programa de Investigación Asociativa en Cáncer Gástrico (PIA-CG), Talca 3460000, Chile. .
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2019 Oct 24; Vol. 20 (21). Date of Electronic Publication: 2019 Oct 24.
Typ publikacji:
Journal Article
MeSH Terms:
Cellular Senescence*/drug effects
Blood Platelets/*metabolism
Blood Platelets/cytology ; Cell Adhesion/drug effects ; Cell Line, Tumor ; Cell Movement/drug effects ; Culture Media, Conditioned/chemistry ; Culture Media, Conditioned/pharmacology ; Cytokines/analysis ; Humans ; Piperazines/pharmacology ; Plasminogen Activator Inhibitor 2/metabolism ; Platelet Aggregation/drug effects ; Pyridines/pharmacology ; Transcriptome/drug effects
Czasopismo naukowe
Tytuł:
The role of proteasome beta subunits in gastrin-mediated transcription of plasminogen activator inhibitor-2 and regenerating protein1.
Autorzy:
O'Hara A; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
Howarth A
Varro A
Dimaline R
Pokaż więcej
Źródło:
PloS one [PLoS One] 2013; Vol. 8 (3), pp. e59913. Date of Electronic Publication: 2013 Mar 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gastrins/*pharmacology
Lithostathine/*genetics
Plasminogen Activator Inhibitor 2/*genetics
Proteasome Endopeptidase Complex/*metabolism
Protein Subunits/*metabolism
Transcription, Genetic/*drug effects
Animals ; Cell Line, Tumor ; Cell Nucleus/drug effects ; Cell Nucleus/enzymology ; Gene Knockdown Techniques ; Humans ; Lithostathine/metabolism ; Plasminogen Activator Inhibitor 2/metabolism ; Promoter Regions, Genetic ; Protein Transport/drug effects ; Rats
Czasopismo naukowe
Tytuł:
Revisiting the biological roles of PAI2 (SERPINB2) in cancer.
Autorzy:
Croucher DR; Cancer Research Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales, Australia 2010.
Saunders DN
Lobov S
Ranson M
Pokaż więcej
Źródło:
Nature reviews. Cancer [Nat Rev Cancer] 2008 Jul; Vol. 8 (7), pp. 535-45. Date of Electronic Publication: 2008 Jun 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Neoplasms/*physiopathology
Plasminogen Activator Inhibitor 2/*physiology
Animals ; Humans ; Hydrolysis ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Neoplasms/metabolism ; Neoplasms/pathology ; Plasminogen/metabolism ; Plasminogen Activator Inhibitor 2/chemistry ; Plasminogen Activator Inhibitor 2/metabolism ; Protein Conformation
Czasopismo naukowe
Tytuł:
SerpinB2 deficiency modulates Th1⁄Th2 responses after schistosome infection.
Autorzy:
Schroder WA; Queensland Institute of Medical Research, Brisbane, Qld., Australia.
Gardner J
Le TT
Duke M
Burke ML
Jones MK
McManus DP
Suhrbier A
Pokaż więcej
Źródło:
Parasite immunology [Parasite Immunol] 2010 Nov-Dec; Vol. 32 (11-12), pp. 764-8.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Plasminogen Activator Inhibitor 2/*physiology
Schistosoma japonicum/*immunology
Schistosomiasis japonica/*immunology
Th1 Cells/*immunology
Th2 Cells/*immunology
Animals ; Arginase/biosynthesis ; Cytokines/biosynthesis ; Gene Expression Profiling ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Nitric Oxide Synthase Type II/biosynthesis ; Plasminogen Activator Inhibitor 2/deficiency ; Schistosomiasis japonica/parasitology ; Schistosomiasis japonica/pathology
Czasopismo naukowe
Tytuł:
SerpinB2 deficiency in mice reduces bleeding times via dysregulated platelet activation.
Autorzy:
Schroder WA; a QIMR Berghofer Medical Research Institute , Brisbane , Australia.
Le TT; a QIMR Berghofer Medical Research Institute , Brisbane , Australia.
Gardner J; a QIMR Berghofer Medical Research Institute , Brisbane , Australia.
Andrews RK; b Australian Centre for Blood Diseases , Monash University , Melbourne , Australia.
Gardiner EE; c ACRF Department of Cancer Biology and Therapeutics , The John Curtin School of Medical Research, The Australian National University , Canberra , Australia.
Callaway L; d Women's and Newborn Services , Royal Brisbane and Women's Hospital , Brisbane , Australia.
Suhrbier A; a QIMR Berghofer Medical Research Institute , Brisbane , Australia.
Pokaż więcej
Źródło:
Platelets [Platelets] 2019; Vol. 30 (5), pp. 658-663. Date of Electronic Publication: 2018 Nov 02.
Typ publikacji:
Journal Article
MeSH Terms:
Bleeding Time*
Platelet Activation*
Blood Coagulation/*genetics
Blood Platelets/*metabolism
Plasminogen Activator Inhibitor 2/*deficiency
Animals ; Biomarkers ; Female ; Immunohistochemistry ; Mice ; Mice, Knockout ; Pregnancy ; Thrombosis ; Urokinase-Type Plasminogen Activator
Czasopismo naukowe
Tytuł:
The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2.
Autorzy:
Medcalf RL; Australian Centre for Blood Diseases, Monash University, Prahran, Victoria, Australia. />Stasinopoulos SJ
Pokaż więcej
Źródło:
The FEBS journal [FEBS J] 2005 Oct; Vol. 272 (19), pp. 4858-67.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Plasminogen Activator Inhibitor 2/*metabolism
Serine Proteinase Inhibitors/*metabolism
Animals ; Apoptosis ; Gene Expression Regulation ; Humans ; Neoplasm Metastasis/pathology ; Plasminogen Activator Inhibitor 2/chemistry ; Plasminogen Activator Inhibitor 2/genetics ; Serine Proteinase Inhibitors/chemistry ; Serine Proteinase Inhibitors/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies